The ethics of hepatitis C "treatment as prevention" among prisoners

Hepatology

Volumn 61, Issue 1, 2015, Pages 402-

  Levy, Michael H ^a   Larney, Sarah ^b  

^a JUSTICE HEALTH AND FORENSIC MENTAL HEALTH NETWORK   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHICS; HARM REDUCTION; HEALTH CARE POLICY; HEPATITIS C; HUMAN; LETTER; MEDICAL STAFF; NEEDLE; OPIATE SUBSTITUTION TREATMENT; PERSUASIVE COMMUNICATION; PRIORITY JOURNAL; PRISON; PRISONER; REINFECTION; SUBSTANCE ABUSE; SYRINGE; MEDICAL ETHICS; SOCIAL CONTROL;

ETHICS, MEDICAL; HEPATITIS C; PRISONERS; SOCIAL CONTROL, FORMAL;

EID: 84921026171     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27195     Document Type: Letter

References (5)

1. Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, et al. The incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology 2013;58:1215-1224.
2. Spaulding AC, Thomas DL. Screening for HCV infection in jails. JAMA 2012;307:1259-1260.
3. Larney S, Mahowald M, Scharff N, Flanigan TP, Beckwith CG, Zaller ND. Epidemiology of hepatitis C virus in Pennsylvania state prisons 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health [Epub ahead of print].
4. Martin NK, Vickerman P, Grebely J, Hellard ME, Hutchinson S, Lima VD, et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology 2013;58:1598-1609.
5. Bate JP, Colman AJ, Frost PJ, Shaw DR, Harley HAJ. High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C. J Gastroenterol Hepatol 2010;25:1276-1280.